Long-term effectiveness and safety of an autologous leukocyte-platelet-rich plasma injection( L-PRP) for the human musculoskeletal injuries.

Long-term effectiveness and safety of an autologous leukocyte-platelet-rich plasma injection( L-PRP) for the human musculoskeletal injuries. - Long-term effectiveness and safety of an autologous leukocyte-platelet-rich plasma injection( L-PRP) for the human musculoskeletal injuries.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035114

Enrollment

Registered

2018-12-03

Start date

2018-12-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the enthesitis, enthesopathy and ligament injuries

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who has the enthesis, enthesitis and ligament injuries. The patient who consents The patient who does not have infections

Exclusion criteria

Exclusion criteria: The patient who has infections The patient who has fever over 37.0 degrees The patient who has a wound The patient who has oral treatment

Design outcomes

Primary

Measure	Time frame
pain, tenderness, Visual Analog Scale and Scale of returning to play after 1, 4, 8, 12 weeks from the injection	—

Countries

Japan

Contacts

Public ContactYusuke Murayama

Department of Sports and Wellness Clinic, The Jikei University School of Medicine Department of Sports and Wellness Clinic

ms05yusukemurayama@gmail.com03-3433-1111

Outcome results